Brief: Aytu Biopharma Inc - Announces Submission Of Cotempla Xr-Odt Manufacturing Site Transfer Prior Approval Supplement

Aytu Biopharma

10/07/2023 13:48

Aytu Biopharma Inc  AYTU.O :
    * AYTU BIOPHARMA INC -  ANNOUNCES SUBMISSION OF COTEMPLA
XR-ODT
MANUFACTURING SITE TRANSFER PRIOR APPROVAL SUPPLEMENT
    * AYTU BIOPHARMA INC - EXPECTS A SIX-MONTH REVIEW OF PAS
SUBMISSION, WHICH WOULD ENABLE FDA APPROVAL BY LATE CALENDAR
2023 OR EARLY CALENDAR 2024
    * AYTU BIOPHARMA INC - EXPECT TO START REALIZING MARGIN
IMPROVEMENTS FOR ADHD BRANDS IN EARLY CALENDAR 2024
    * AYTU BIOPHARMA -EXPECTS TO IMPROVE ADHD PRODUCT MARGINS BY
ESTIMATED 15% UPON COMPLETION OF MANUFACTURING TRANSFER OF
ADZENYS XR-ODT & COTEMPLA XR-ODT

Source text for Eikon:  ID: 
Further company coverage:  AYTU.O